CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 37,499 | ||
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 41,666 | ||
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise | +1,953 | $1.02 | $2K | 246,830 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise | +18,749 | $2.50 | $47K | 265,579 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise | +2,604 | $1.40 | $4K | 268,183 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −33,049 | $16.33 | $540K | 235,134 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −8,800 | $17.47 | $154K | 226,334 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Sale | −8,400 | $17.99 | $151K | 217,934 |
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −1,953 | 7,812 | ||
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −18,749 | 168,760 | ||
| 2018-10-01 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,604 | 41,666 | ||
| 2018-09-30 | THERO JOHN F President and CEO | Option exercise | +37,500 | 2,309,285 | ||
| 2018-09-30 | THERO JOHN F President and CEO | Shares withheld for taxes | −14,757 | $16.27 | $240K | 2,294,528 |
| 2018-09-30 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −37,500 | 112,500 | ||
| 2018-09-30 | Kennedy Joseph T General Counsel | Option exercise | +47,188 | 265,122 | ||
| 2018-09-30 | Kennedy Joseph T General Counsel | Option exercise | +6,250 | 271,372 | ||
| 2018-09-30 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −26,495 | $16.27 | $431K | 244,877 |
| 2018-09-30 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −47,188 | 141,562 | ||
| 2018-09-30 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −6,250 | 18,750 | ||
| 2018-09-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +200,000 | $8.77 | $1.8M | 541,297 |
Page 81 of 95 · 1,885 trades